Pharmacologic Treatment of Sex Offenders With Paraphilic Disorder

  • Frederico Duarte Garcia
  • Heloise Garcia Delavenne
  • Alessandra de Fátima Almeida Assumpção
  • Florence Thibaut
Sexual Disorders (JP Fedoroff, Section Editor)

DOI: 10.1007/s11920-013-0356-5

Cite this article as:
Garcia, F.D., Delavenne, H.G., Assumpção, A.F.A. et al. Curr Psychiatry Rep (2013) 15: 356. doi:10.1007/s11920-013-0356-5
Part of the following topical collections:
  1. Topical Collection on Sexual Disorders

Abstract

Sexual offending is both a social and a public health issue. Evidence demonstrates that a combination of pharmacological and psychotherapeutic approaches may reduce or even eliminate deviant sexual behavior in sex offenders with paraphilic disorders. In this article, we will review pharmacological treatment options for sex offenders with paraphilias. Both serotonin selective reuptake inhibitors (SSRIs) and antiandrogen treatments have been used with reported success in decreasing recidivism. SSRIs have been used in mild types of paraphilias and juvenile paraphilias. Antiandrogen treatments seem to be effective in severe sex offenders with paraphilic disorders in order to reduce victimization. Combined pharmacological and psychotherapeutic treatment is associated with better efficacy. Imaging studies may improve the knowledge of paraphilic disorders and the mechanisms of action of current treatments. In spite of existing evidence, there is a need for independent, large-scale and good quality studies assessing the long-term efficacy and tolerance of treatments.

Keywords

Sex Offender Paraphilia Pedophilia Pharmacologic Treatment Selective Serotonin Reuptake Inhibitor SSRI Androgen Deprivation Therapy Steroidal Antiandrogen Treatments Medroxyprogesterone Acetate MPA Cyproterone Acetate CPA Gonadotropin-Releasing Hormone Analog GnRHa Goserelin Leuprorelin Triptorelin Sexual Disorders Psychiatry 

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Frederico Duarte Garcia
    • 1
    • 2
  • Heloise Garcia Delavenne
    • 1
  • Alessandra de Fátima Almeida Assumpção
    • 1
  • Florence Thibaut
    • 3
  1. 1.Department of Psychiatry, INCT - de Medicina Molecular, Faculdade de Medicina Universidade Federal de Minas Gerais (UFMG)Belo HorizonteBrazil
  2. 2.Inserm Unit 1073Rouen UniversityRouenFrance
  3. 3.Rouen University HospitalFaculty of Medicine, INSERM U675RouenFrance

Personalised recommendations